Ethical issues of psychotropic medication for people with intellectual disabilities

Advances in Mental Health and Intellectual Disabilities

Volumn 4, Issue 3, 2010, Pages 34-38

  Raghavan, Raghu ^a   Patel, Pradip ^b  

^a NORTHUMBRIA UNIVERSITY   (United Kingdom)

^b LANCASHIRE CARE NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Ethical and legal issues; Intellectual disability; Learning disabilities; Medication

Indexed keywords

EID: 84993063590     PISSN: 20441282     EISSN: 20441290     Source Type: Journal    
DOI: 10.5042/amhid.2010.0541     Document Type: Review

References (22)

1. Adults with Incapacity (Scotland) Act 2000.
2. Arnold L.E. (1993) Clinical pharmacological issues in treating psychiatric disorders of patients with mental retardation. Annals of Clinical Psychiatry 5 189-198.
3. Clarke D.J., Kelley S., Thinn K., et al. (1990) Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings. Journal of Mental Deficiency Research 34 385-395.
4. Cookson J., Taylor D. & Katona C. (2002) Use of Drugs in Psychiatry. Gaskell, Royal College of Psychiatrists.
5. Day J.C., Wood G., Dewey M. & Bentall R.P. (1995) Lunsers a selfrating scale for measuring neuroleptic side-effects. British Journal of Psychiatry 166 (5) 650-653.
6. Deb S., Clark D. & Unwin (2006) Using Medication to Manage Behaviour Problems among Adults with a Learning Disability: QRG. University of Birmingham, MENCAP, Royal College of Psychiatrists.
7. Deb S. & Fraser W. (1994) The use of psychotropic medication in people with learning disability: towards rational prescribing. Human Psychopharmacology 9 259-272.
8. Department of Constitutional Affairs (2005) Mental Capacity Act 2005. Norwich: The Stationery Office.
9. DH (Department of Health) (2001) Valuing People: A new strategy for Learning Disability for the 21st century. Norwich: The Stationery Office.
10. DH (2008) Mental Health Act 1983 Code of Practice 2008 Revision. London: Department of Health.
11. DH (2009) Valuing People Now: A new three-year strategy on learning disabilities. London: Department of Health.
12. General Medical Council (2008) Consent: Patients and doctors making decisions together. General Medical Council, June.
13. Hall S. & Deb S. (2008) A qualitative study on the knowledge and views that people with learning disabilities and their carers have of psychotropic medication prescribed for behavioural problems. Advances in Mental Health and Learning Disabilities 2 (1) 29-37.
14. Holland A. (2003) Consent and decision making capacity. In: W Fraser & M Kerr (Eds) Seminars in the Psychiatry of Learning Disabilities. London: Gaskell.
15. Mental Health Act 1983 (as amended by Mental Health Act 2007).
16. Molyneaux P., Emerson E. & Caine A. (2000) Prescription of psychotropic medication to people with intellectual disabilities in primary health care settings. Journal of Applied Research in Intellectual Disability 12 46-57.
17. Monitoring of Side Effects Scale (MOSES). www.dshs.wa.gov/pdf/ms/forms/10_334.pdf.
18. Nursing and Midwifery Council (2001) Position Statement on Covert Administration of Medicines. London: NMC.
19. Reiss S. & Aman M. (1997) The international consensus process on psychopharmacology and intellectual disability. Journal of Intellectual Disability Research 41 448-455.
20. Sprague R.L. & Kalachnik J.E. (1991) Reliability, validity and total score cutoff for the Dyskinesia Identification System: Condensed User Scale (DISCUS) with mentally ill and mentally retarded populations. Psychopharmacology Bulletin 27 51-58.
21. Thompson C. (1994) The use of high dose antipsychotic medication. British Journal of Psychiatry 164 448-458.
22. Tyrer P. C., Oliver-Africano P., et al. (2008) Risperidone, haloperidol and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial. The Lancet 371 57-63.